InsiderSignal.AI

InsiderSignal.ai

CARL - Carlsmed, Inc.

Insider Purchase by B Capital Group Management, L.P. (10%)

1 Year
After Trade
Before Trade

Loading data...

Trade Summary

7 months ago, B Capital Group Management, L.P., serving as 10% owner at Carlsmed, Inc. (CARL), purchased 1,333,333 shares at $15.00 per share, for a total transaction value of $19,999,995.00. Following this transaction, B Capital Group Management, L.P. now holds 8,321,763 shares of CARL.

This purchase represents a 19.00% increase in B Capital Group Management, L.P.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, July 24, 2025 and publicly disclosed via SEC Form 4 filing on Thursday, July 24, 2025, meaning the disclosure happened on the same day as the trade.

Carlsmed, Inc. operates in the HEALTHCARE sector, specifically within the HEALTH INFORMATION SERVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

B Capital Group Management, L.P.

10%

B Capital Group Management, L.P. is a venture capital firm headquartered in Manhattan Beach, California, founded in 2015 by Facebook co-founder Eduardo Saverin and Raj Ganguly, with Howard L. Morgan serving as chairman.[[1]](https://b.capital/about/)[[4]](https://en.wikipedia.org/wiki/B_Capital)[[5]](https://www.swfinstitute.org/profile/5e39a49cfcbe7e8ca71b0f6b) The firm manages over $9 billion in assets, supporting more than 200 early- to late-stage portfolio companies across Technology, Healthcare, Energy & Resilience, and other sectors, through dedicated stage-based funds and a strategic partnership with Boston Consulting Group for operational support.[[1]](https://b.capital/about/)[[2]](https://b.capital)[[3]](https://www.zoominfo.com/c/b-capital-group/379469959) B Capital operates globally with 9 locations, including offices in San Francisco, New York, Los Angeles, Singapore, Beijing, and Hong Kong, emphasizing a multinational approach to identify and scale opportunities from the US to Asia.[[1]](https://b.capital/about/)[[2]](https://b.capital)[[4]](https://en.wikipedia.org/wiki/B_Capital) As a corporate insider, it recently traded at 10% ownership in Carlsmed, Inc. (CARL), reflecting its active involvement in healthcare investments, such as its $500 million healthcare-only fund raised in 2023.[[4]](https://en.wikipedia.org/wiki/B_Capital)[[6]](https://b.capital/portfolio/)

View full insider profile →

Trade Price

$15.00

Quantity

1,333,333

Total Value

$19,999,995.00

Shares Owned

8,321,763

Trade Date

Thursday, July 24, 2025

213 days ago

SEC Filing Date

Thursday, July 24, 2025

HEALTHCAREHEALTH INFORMATION SERVICES

About Carlsmed, Inc.

Company Overview

No company information available
View news mentioning CARL

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/85995

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime